These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 31472333)
1. A review of Lassa fever vaccine candidates. Salami K; Gouglas D; Schmaljohn C; Saville M; Tornieporth N Curr Opin Virol; 2019 Aug; 37():105-111. PubMed ID: 31472333 [TBL] [Abstract][Full Text] [Related]
2. A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene. Cai Y; Ye C; Cheng B; Nogales A; Iwasaki M; Yu S; Cooper K; Liu DX; Hart R; Adams R; Brady T; Postnikova EN; Kurtz J; St Claire M; Kuhn JH; de la Torre JC; Martínez-Sobrido L mBio; 2020 Feb; 11(1):. PubMed ID: 32098811 [TBL] [Abstract][Full Text] [Related]
3. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628 [TBL] [Abstract][Full Text] [Related]
4. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Branco LM; Grove JN; Geske FJ; Boisen ML; Muncy IJ; Magliato SA; Henderson LA; Schoepp RJ; Cashman KA; Hensley LE; Garry RF Virol J; 2010 Oct; 7():279. PubMed ID: 20961433 [TBL] [Abstract][Full Text] [Related]
5. Current research for a vaccine against Lassa hemorrhagic fever virus. Warner BM; Safronetz D; Stein DR Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299 [TBL] [Abstract][Full Text] [Related]
6. Advanced vaccine candidates for Lassa fever. Lukashevich IS Viruses; 2012 Oct; 4(11):2514-57. PubMed ID: 23202493 [TBL] [Abstract][Full Text] [Related]
7. The search for animal models for Lassa fever vaccine development. Lukashevich IS Expert Rev Vaccines; 2013 Jan; 12(1):71-86. PubMed ID: 23256740 [TBL] [Abstract][Full Text] [Related]
8. A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region. Cai Y; Iwasaki M; Motooka D; Liu DX; Yu S; Cooper K; Hart R; Adams R; Burdette T; Postnikova EN; Kurtz J; St Claire M; Ye C; Kuhn JH; Martínez-Sobrido L; de la Torre JC mBio; 2020 Mar; 11(2):. PubMed ID: 32209677 [TBL] [Abstract][Full Text] [Related]
9. Vaccine platforms for the prevention of Lassa fever. Purushotham J; Lambe T; Gilbert SC Immunol Lett; 2019 Nov; 215():1-11. PubMed ID: 31026485 [TBL] [Abstract][Full Text] [Related]
10. VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever. Leblanc P; Moise L; Luza C; Chantaralawan K; Lezeau L; Yuan J; Field M; Richer D; Boyle C; Martin WD; Fishman JB; Berg EA; Baker D; Zeigler B; Mais DE; Taylor W; Coleman R; Warren HS; Gelfand JA; De Groot AS; Brauns T; Poznansky MC Hum Vaccin Immunother; 2014; 10(10):3022-38. PubMed ID: 25483693 [TBL] [Abstract][Full Text] [Related]
11. Vaccine platforms to control Lassa fever. Lukashevich IS; Pushko P Expert Rev Vaccines; 2016 Sep; 15(9):1135-50. PubMed ID: 27136941 [TBL] [Abstract][Full Text] [Related]